- You are here: Home
- Disease Models
- Inflammation & Autoimmune Disease Models
- Glomerulonephritis Models
- Acute Puromycin Aminonucleoside (PAN) Model
Disease Models
- Oncology Models
-
Inflammation & Autoimmune Disease Models
- Rheumatoid Arthritis Models
- Glomerulonephritis Models
- Multiple Sclerosis (MS) Models
- Ocular Inflammation Models
- Sjögren's Syndrome Model
- LPS-induced Acute Lung Injury Model
- Peritonitis Models
- Passive Cutaneous Anaphylaxis Model
- Delayed-Type Hypersensitivity (DTH) Models
- Inflammatory Bowel Disease Models
- Systemic Lupus Erythematosus Animal Models
- Asthma Model
- Sepsis Model
- Psoriasis Model
- Atopic Dermatitis (AD) Model
- Scleroderma Model
- Gouty Arthritis Model
- Carrageenan-Induced Air Pouch Synovitis Model
- Carrageenan-Induced Paw Edema Model
- Experimental Autoimmune Myasthenia Gravis (EAMG) Model
- Cardiovascular Disease Models
-
Neurological Disease Models
- Alzheimer's Disease Modeling and Assays
- Seizure Models
- Parkinson's Disease Models
- Ischemic Stroke Models
- Acute Spinal Cord Injury (ASCI) Model
- Traumatic Brain Injury (TBI) Model
- Hypoxic-Ischemic Encephalopathy (HIE) Model
- Tourette Syndrome (TS) Model
- Amyotrophic Lateral Sclerosis (ALS) Model
- Huntington's Disease (HD) Model
- Intracerebral hemorrhage (ICH) Models
- Pain Models
- Metabolic Disease Models
- Liver Disease Models
- Rare Disease Models
- Respiratory Disease Models
- Digestive Disease Models
-
Urology Disease Models
- Cisplatin-induced Nephrotoxicity Model
- Unilateral Ureteral Obstruction Model
- 5/6 Nephrectomy Model
- Renal Ischemia-Reperfusion Injury (RIRI) Model
- Diabetic Nephropathy (DN) Models
- Passive Heymann Nephritis (PHN) Model
- Adenine-Induced Chronic Kidney Disease (CKD) Model
- Kidney Stone Model
- Doxorubicin-Induced Nephropathy Model
- Orthopedic Disease Models
- Ocular Disease Models
Acute Puromycin Aminonucleoside (PAN) Model
Focal and segmental glomerulosclerosis (FSG) is a chronic glomerulopathy whose pathogenesis remains poorly understood. It is estimated that FSG accounts for 2.5% of all causes for chronic kidney disease with difficulties to deal with. Puromycin aminonucleoside induced glomerulosclerosis is a less expensive and time-saving model which is often characterized by nephrotic syndromes with podocyte lesions, mesangial expansion, endothelial swelling obliterating the capillary lumen, and increased glomerular volume.
Creative Bioarray focuses on drug research and development services and helps customers evaluate the drug efficacy and study the associated pathological mechanisms of FSG by acute puromycin aminonucleoside (PAN) model.
Our capabilities
- We utilize Acute Puromycin Aminonucleoside (PAN) Model to test the efficacy of drug candidates targeting FSG.
- We assess the severity of lesion through glomerular damage score system.
- We detect the infiltration of monocyte/macrophage via IHC.
- We evaluate various cytokines through IHC, ELISA, etc.
Assays available
- PK/PD blood collections
- Detection of blood creatinine
- BUN
- Proteinuria
- Histopathological evaluation
With extensive experience in the field of FSG, we are confident to help you to overcome any upcoming challenges. Our experts are fully capable of customizing our protocols and assays to meet your specific needs. With our help, we wish to facilitate your research with high efficiency.
Study examples
Figure. 1. Urinary protein excretion (mg/24 h) of the groups after 30, 60, and 90 days.
Figure. 2. Fibronectin immunostaining in renal cortex from the groups: Control (A), LMWH (B), PAN (C), and PAN+LMWH (D) (magnification 400).
Quotation and ordering
If you have any special needs or questions regarding our services, please feel free to contact us. We look forward to cooperating with you in the future.
Reference
Santos A M R D, Olveira A V D, et al. Low molecular weight heparin in the treatment of puromycin-induced nephrosis[J]. Pathology Research & Practice, 2006, 202(3):157-163.
For research use only. Not for any other purpose.
